Tullia C. Bruno
- Immunology top 0.2%
- Immune Cell Function and Interaction 36
- Immunotherapy and Immune Responses 28
- T-cell and B-cell Immunology 13
- Immune cells in cancer 12
- IL-33, ST2, and ILC Pathways 4
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers 54
- CAR-T cell therapy research 19
- Otorhinolaryngology top 1%
- Cancer Research top 2%
-
- Cancer, Stress, Anesthesia, and Immune Response 3
- Co-authors
- Dario A.A. VignaliCharles G. DrakeCreg J. WorkmanDrew M. PardollDerese GetnetRobert L. FerrisJoseph F. GrossoMonica V. Goldberg
- Journals
- Cell (3 papers)Proceedings of the National Academy of Sciences (3 papers)Journal of Clinical Investigation (2 papers)
- Partner nations
- United StatesTaiwanChina
In The Last Decade
Tullia C. Bruno
83 papers receiving 7.2k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Immunology 4.4k
- Oncology 4.2k
- Otorhinolaryngology 285
- Cancer Research 748
- Pulmonary and Respiratory Medicine 1.0k
Countries citing papers authored by Tullia C. Bruno
This map shows the geographic impact of Tullia C. Bruno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tullia C. Bruno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tullia C. Bruno more than expected).
Fields of papers citing papers by Tullia C. Bruno
This network shows the impact of papers produced by Tullia C. Bruno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tullia C. Bruno. The network helps show where Tullia C. Bruno may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tullia C. Bruno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 4 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 24 | |
| 5 | 2024 | 4 | |
| 6 | Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic visionbreakdown → | 2024 | 64 |
| 7 | 2024 | 1 | |
| 8 | 2023 | 16 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 13 | |
| 11 | 2022 | 18 | |
| 12 | 2022 | 51 | |
| 13 | 2022 | 12 | |
| 14 | 2022 | 133 | |
| 15 | 2021 | 54 | |
| 16 | 2020 | 59 | |
| 17 | 2018 | 103 | |
| 18 | 2014 | 65 | |
| 19 | Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinomabreakdown → | 2013 | 602 |
| 20 | 2009 | 161 |
About Tullia C. Bruno
Tullia C. Bruno is a scholar working on Immunology, Oncology and Otorhinolaryngology, having authored 91 papers that have together received 7.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (54 papers), Immune Cell Function and Interaction (36 papers), Immunotherapy and Immune Responses (28 papers), CAR-T cell therapy research (19 papers), T-cell and B-cell Immunology (13 papers), Immune cells in cancer (12 papers), IL-33, ST2, and ILC Pathways (4 papers) and Cancer, Stress, Anesthesia, and Immune Response (3 papers). The work is most often cited by research in Immunology (4.4k citations), Oncology (4.2k citations) and Otorhinolaryngology (285 citations). Tullia C. Bruno has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Dario A.A. Vignali, Charles G. Drake, Creg J. Workman, Drew M. Pardoll, Derese Getnet, Robert L. Ferris, Joseph F. Grosso, Monica V. Goldberg, Anthony R. Cillo and Edward L. Hipkiss. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.